How cutaneous eruptions help to understand the mode of action of kinase inhibitors

Br J Dermatol. 2012 Nov;167(5):965-7. doi: 10.1111/bjd.12080.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Eruptions / etiology*
  • Humans
  • Indoles / adverse effects
  • MAP Kinase Kinase Kinases / antagonists & inhibitors
  • Protein Kinase Inhibitors / adverse effects*
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors
  • Skin Neoplasms / chemically induced*
  • Sulfonamides / adverse effects
  • Vemurafenib

Substances

  • Indoles
  • Protein Kinase Inhibitors
  • Sulfonamides
  • Vemurafenib
  • Proto-Oncogene Proteins B-raf
  • MAP Kinase Kinase Kinases